ULTRA clinical trial: Prospective comparative clinical outcome analysis of three different RAS/BRAF sensitivity mutational cut-offs. A Phase II study of the Spanish TTD Group

Autor: D. Azuara, Gabriel Capellá, Manuel Valladares-Ayerbes, G. Duran Ogaya, C. Buges, E. Falcó, Elena Elez, V. Navarro, E. Aranda Aguilar, David Páez, Carlos Ferreira dos Santos, C. López López, P. García-Alfonso, Jose María Vieitez, M.A. Salud Salvia, Luis Robles, R. Salazar

Publikováno v: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f9391b45a5010b12f41dc50274e3a9
https://doi.org/10.1093/annonc/mdx393.073

Limited value of currently used germline brca mutations predictive tools in prostate cancer

Autor: G. Duran Ogaya, M. Ruiz Vico, Nuria Romero-Laorden, Reginaldo O. Corrêa, M.A. Márquez-Aragonés, D. Olmos Hidalgo, Javier Pascual, M.E. Dominguez Recio, L. Oliva Fernandez, C. Fernández de Souza, C. Muriel, M.I. Sáez, G. Grau, B.I. Pajares Hachero, Irene Moreno, A. Montesa

Publikováno v: Annals of Oncology. 28:v286

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef6017669fbade96a03707bfe47da9fa
https://doi.org/10.1093/annonc/mdx370.042